Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625 1634 1691
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18566008 | COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17762325 | TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS | Non-Final OA | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) |
| 18629321 | SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Non-Final OA | EPIGENETIX, INC. |
| 18596840 | METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE | Non-Final OA | Lake O'Hara LLC |
| 18514875 | METHODS FOR AMELIORATING AND PREVENTING AGE-RELATED MUSCLE DEGENERATION | Non-Final OA | NANJING NUTRABUILDING BIO-TECH CO., LTD. |
| 18419894 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | Non-Final OA | Celgene Corporation |
| 18562768 | BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION | Non-Final OA | BELITE BIO, LLC |
| 17973119 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Non-Final OA | Gilgamesh Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy